Affirmation of Vanderbilt University Medical Center’s high profile in precision medicine came last week when a new working group convened by the National Institutes of Health (NIH) visited Vanderbilt for a two-day public workshop devoted to planning a key component of the federal Precision Medicine Initiative announced earlier this year by President Obama.
Unstable federal research funding and reductions in health care revenue for academic medical centers threatens to undermine the nation’s biomedical research enterprise, and in turn clinical medicine, which the nation needs now more than ever.
National Institutes of Health Director Francis Collins, M.D., Ph.D., will deliver a special Discovery Lecture at Vanderbilt University Medical Center next Thursday, May 28.
The enzyme alkaline phosphatase may provide a new therapeutic option for women at high risk of pregnancy complications due to bacterial toxin exposure.
Vanderbilt University researchers have received a five-year, $9 million grant from the National Institutes of Health (NIH) to design more effective flu vaccines and novel antibody therapies.
A metabolic change in adult stem cells makes them less “fit” for regenerative heart therapies, suggesting that strategies to prevent this response may boost the therapeutic usefulness of the cells.